Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Sun Pharma to acquire Organon & Co for $11.75B

PRIVATESep 08, 2026•about 2 hours ago

Acquiring Company

Sun Pharmaceutical Industries

Acquired Company

Organon & Co

MumbaiUnited States Virgin IslandsBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth Care

Description

Sun Pharmaceutical Industries announced its binding bid to acquire Organon & Co for USD 11.75 billion. The acquisition aims to enhance Sun Pharma's market position and revenue, nearly doubling its base. The deal is expected to close by March 2027, pending regulatory approvals. This acquisition will significantly boost Sun's operations in women's health and biosimilars.

Company Information

Company

Sun Pharmaceutical Industries

Location

Mumbai, Maharashtra, India

About

Sun Pharmaceutical Industries is a global pharmaceutical company based in India. It specializes in providing high-quality medicines across various therapeutic areas, including oncology. The company is committed to improving patient outcomes through innovative drug development. Sun Pharma is known for its strategic acquisitions to enhance its product portfolio.

Don't miss Sun Pharmaceutical Industries's next move

Get an email the moment Sun Pharmaceutical Industries makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Sun Pharmaceutical Industries's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Organon & Co?

Organon & Co was acquired by Sun Pharmaceutical Industries, based in Mumbai. The deal was reported on September 8, 2026. Sun Pharmaceutical Industries is a global pharmaceutical company based in India. It specializes in providing high-quality medicines across various therapeutic areas, including oncology. Sun Pharmaceutical Industries is privately held and operates in Biotechnology.

When did Sun Pharmaceutical Industries acquire Organon & Co?

Sun Pharmaceutical Industries's acquisition of Organon & Co was reported on September 8, 2026. Sun Pharmaceutical Industries announced its binding bid to acquire Organon & Co for USD 11.75 billion. The acquisition aims to enhance Sun Pharma's market position and revenue, nearly doubling its base. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Organon & Co do?

Organon is a global healthcare company formed through a spinoff from Merck & Co. It focuses on market-leading therapeutic solutions targeting women's health and other key health areas. It is privately held, operating in Biotechnology, and is based in United States Virgin Islands.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.